Diabetics

Diabetic nephropathy (DN) is typically defined by macro albuminuria—that is, a urinary albumin excretion of more than 300 mg in a 24-hour collection—or macro albuminuria and abnormal renal function as represented by an abnormality in serum creatinine, calculated creatinine clearance, or glomerular filteration filtration rate (GFR). Clinically, diabetic nephropathy is characterized by a progressive increase in proteinuria and decline in GFR, hypertension, and a high risk of cardiovascular morbidity and mortality. Diabetic nephropathy is a clinical syndrome characterized by the following: Proteinuria was first recognized in diabetes mellitus in the late 18th century.

By the 1950s, kidney disease was clearly recognized as a common complication of diabetes, with as many as 50% of patients with diabetes of more than 20 years having this complication Currently, diabetic nephropathy is the leading cause of chronic kidney disease in the United States and other Western societies. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes. Diabetes is responsible for 30-40% of all end-stage renal disease (ESRD) cases in the United States. Generally, diabetic nephropathy is considered after a routine urinalysis and screening for micro albuminuria in the setting of diabetes. Patients may have physical findings associated with long-standing diabetes mellitus. Good evidence suggests that early treatment delays or prevents the onset of diabetic nephropathy or diabetic kidney disease. Regular outpatient follow-up is key in managing diabetic nephropathy successfully. Recently, attention has been called to atypical presentations of diabetic nephropathy with dissociation of proteinuria from reduced kidney function. Also noted is that micro albuminuria is not always predictive of diabetic nephropathy

  • Diabetic Microvascular Complications, Diabetic Nephropathy
  • Contrast Nephropathy, Uric acid Nephropathy
  • Diabetic Glomerulosclerosis, IgA Nephropathy
  • Pathogenesis of Diabetic Nephropathy
  • HIV Associated Nephropathy
  • Glycemic Control, Diabetic Ketoacidosis

Related Conference of Diabetics

April 27-28, 2020

16th World Nephrology Conference

Singapore
April 27-28, 2020

5th World Kidney Congress

Dubai, UAE
June 10-11, 2020

21st Global Nephrologists Annual Meeting

Frankfurt, Germany
September 14-15, 2020

17th Asia Pacific Nephrology Conference

Osaka, Japan
September 14-15, 2020

22nd World Nephrologists Summit

Tokyo, Japan
September 16-17, 2020

15th Nephrology,Renal Medicine & Renal Care

Tokyo, Japan
October 12-13, 2020

24th European Nephrology Conference

Zurich, Switzerland
October 26-27, 2020

3rd International Conference on Nephrology

Dubai, UAE
November 09-10, 2020

International Conference on  Urology and Andrology

Bangkok, Thailand
November 23-24, 2020

World Congress and Expo on Nephrology

Hanoi, Vietnam

Diabetics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in